Dealing with highly active multiple sclerosis after natalizumab-associated PML: could rituximab be of help?
Crossref DOI link: https://doi.org/10.1007/s10072-017-3228-7
Published Online: 2018-01-04
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mancinelli, Chiara Rosa http://orcid.org/0000-0001-5884-9646
Scarpazza, C.
Santuccio, G.
De Rossi, N.
Capra, R.
License valid from 2018-01-04